United Therapeutics, DOJ in Possible Settlement Over Drug Contributions
Several U.S. drugmakers are being investigated for nonprofit contributions to help patients pay out-of-pocket drug costs.

United Therapeutics Corp (UTHR) set aside $210 million for a possible settlement with the Department of Justice regarding an investigation into the drugmaker's contributions to patient-assistance charity groups, the Wall Street Journal reported.

The Justice Department is investigating whether the contributions violate federal laws against kickbacks and false claims. A United Therapeutics filing with the Securities and Exchange Commission shows the Silver Spring, Md.-based company is in settlement talks to resolve the investigation, but thinks it could successfully defend itself against any Justice Department action.

United Therapeutics is one of several companies, along with Johnson & Johnson (JNJ) , Pfizer (PFE) and Biogen (BIIB) , under investigation for nonprofit contributions to help patients pay out-of-pocket drug costs. United Therapeutics is the first company to disclose a potential settlement.

United Therapeutics stock traded down over 2% Thursday morning.

More of What's Trending on TheStreet:

More from Stocks

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Video: Here's How Goldman Sachs May Change Under David Solomon

Video: Here's How Goldman Sachs May Change Under David Solomon

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

3 Reasons Why Netflix Bulls Are Getting Their Face Ripped Off After Earnings

3 Reasons Why Netflix Bulls Are Getting Their Face Ripped Off After Earnings

Markets Close Higher After Fed Chair Powell's Capitol Hill Testimony

Markets Close Higher After Fed Chair Powell's Capitol Hill Testimony